© Valitor, Inc 2020

  • LinkedIn - White Circle
Search
  • mmahomed2

Phase I SBIR grant from the National Institute of General Medical Sciences

Valitor has been awarded a Phase I SBIR grant from the National Institute of General Medical Sciences. This project will support the translation of our wound healing platform to a wider range of growth factors and other therapeutic proteins that have demonstrated safety in previous clinical studies. The results of this award will facilitate strategic partnerships and commercialization of our technology.

1 view